https://nizarbitar.com 2026-08-10T00:40:30+01:00 https://nizarbitar.com/about 2026-08-10T10:21:21+01:00 https://nizarbitar.com/hematology 2026-08-10T00:35:42+01:00 https://nizarbitar.com/medical-oncology 2026-08-10T00:35:42+01:00 https://nizarbitar.com/transfusion-medicine 2026-08-10T00:35:42+01:00 https://nizarbitar.com/services 2026-08-10T10:21:21+01:00 https://nizarbitar.com/publications 2026-08-10T10:21:21+01:00 https://nizarbitar.com/media 2026-08-10T10:21:21+01:00 https://nizarbitar.com/booking 2026-08-10T10:47:39+01:00 https://nizarbitar.com/contact 2026-08-10T10:21:21+01:00 https://nizarbitar.com/first-visit 2026-08-10T10:21:21+01:00 https://nizarbitar.com/disclaimer 2026-08-10T10:21:21+01:00 https://nizarbitar.com/fr 2026-08-10T00:40:30+01:00 https://nizarbitar.com/fr/about 2026-08-10T10:21:21+01:00 https://nizarbitar.com/fr/hematology 2026-08-10T00:35:42+01:00 https://nizarbitar.com/fr/medical-oncology 2026-08-10T00:35:42+01:00 https://nizarbitar.com/fr/transfusion-medicine 2026-08-10T00:35:42+01:00 https://nizarbitar.com/fr/services 2026-08-10T10:21:21+01:00 https://nizarbitar.com/fr/publications 2026-08-10T10:21:21+01:00 https://nizarbitar.com/fr/media 2026-08-10T10:21:21+01:00 https://nizarbitar.com/fr/booking 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/contact 2026-08-10T10:21:21+01:00 https://nizarbitar.com/fr/first-visit 2026-08-10T10:21:21+01:00 https://nizarbitar.com/fr/disclaimer 2026-08-10T10:21:21+01:00 https://nizarbitar.com/ar 2026-08-10T00:40:30+01:00 https://nizarbitar.com/ar/about 2026-08-10T10:21:21+01:00 https://nizarbitar.com/ar/hematology 2026-08-10T00:35:42+01:00 https://nizarbitar.com/ar/medical-oncology 2026-08-10T00:35:42+01:00 https://nizarbitar.com/ar/transfusion-medicine 2026-08-10T00:35:42+01:00 https://nizarbitar.com/ar/services 2026-08-10T10:21:21+01:00 https://nizarbitar.com/ar/publications 2026-08-10T10:21:21+01:00 https://nizarbitar.com/ar/media 2026-08-10T10:21:21+01:00 https://nizarbitar.com/ar/booking 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/contact 2026-08-10T10:21:21+01:00 https://nizarbitar.com/ar/first-visit 2026-08-10T10:21:21+01:00 https://nizarbitar.com/ar/disclaimer 2026-08-10T10:21:21+01:00 https://nizarbitar.com/media/professor-nizar-bitar-representing-lsmo-at-the-launch-of-said-ngo-s-march-2023-campaign 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/professor-nizar-bitar-explains-colon-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/professor-nizar-bitar-at-the-said-ngo-hike-to-yahshoush-part-2 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/sahtak-your-health-professor-nizar-bitar-on-nbn-blood-diseases-cancer-care 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/sahtak-your-health-professor-nizar-bitar-on-nbn-hematology-oncology 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/sahtak-your-health-professor-nizar-bitar-on-nbn-head-of-hematology-oncology-at-sahel-general-hospital 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/shi-jdid-something-new-professor-nizar-bitar-on-blood-diseases-and-cancer-nbn 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/cancer-patients-in-lebanon-and-their-many-battles-panel-with-professor-nizar-bitar-lbci-naharkoun-saeed 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/professor-nizar-bitar-s-address-representing-the-dean-of-the-faculty-of-medical-sciences 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/early-breast-cancer-detection-campaign-awareness-lecture-by-professor-nizar-bitar-women-s-advancement-association 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/morning-news-interview-with-professor-nizar-bitar-future-tv 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/early-breast-cancer-detection-awareness-lecture-with-professor-nizar-bitar-october-campaign 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/breast-cancer-awareness-tips-from-professor-nizar-bitar 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/evaluating-cancer-risks-the-impact-of-thirdhand-smoke-exposure-on-carcinogenesis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/complex-presentation-of-multicentric-castleman-disease-with-coexisting-hiv-hhv-8-and-other-opportunistic-infections 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/liquid-biopsy-as-a-tool-for-kras-nras-braf-baseline-testing-in-metastatic-colorectal-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/consensus-on-the-management-of-platinum-sensitive-high-grade-serous-epithelial-ovarian-cancer-in-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/diagnosis-and-management-of-patients-with-stage-iii-non-small-cell-lung-cancer-a-joint-statement-by-the-lebanese-society-of-medical-oncology-and-the-lebanese-pulmonary-society 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/lung-cancer-screening-in-lebanon-joint-statement-from-the-lebanese-pulmonary-society-and-the-lebanese-society-of-medical-oncology 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/pneumococcal-disease-in-high-risk-adults-in-lebanon-expert-opinion 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/incidence-of-braf-v600e-gene-mutation-among-lebanese-population-in-melanoma-and-colorectal-cancer-a-retrospective-study-between-2010-and-2019 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/the-first-middle-east-and-north-africa-expert-consensus-recommendations-for-the-management-of-advanced-colorectal-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/overcoming-therapy-resistance-in-colon-cancer-by-drug-repurposing 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/large-cell-neuroendocrine-carcinoma-of-the-colon-with-brain-metastasis-a-case-report 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/dermatomyositis-a-presenting-clinical-vignette-in-a-patient-with-breast-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/a-case-report-first-report-of-a-primary-breast-leiomyosarcoma-with-lymph-node-metastasis-in-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/the-lebanese-society-of-medical-oncology-lsmo-recommendations-and-perspectives-on-oncology-care-during-the-covid-19-pandemic 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/the-lebanese-society-of-medical-oncology-lsmo-statement-on-the-care-of-patients-with-cancer-during-the-covid-19-pandemic 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/management-of-patients-with-high-risk-and-advanced-prostate-cancer-in-the-middle-east-resource-stratified-consensus-recommendations 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/circulating-mir-29c-mir-30c-mir-193a-5p-and-mir-885-5p-novel-potential-biomarkers-for-htlv-1-infection-diagnosis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/female-oncologists-in-the-middle-east-and-north-africa-progress-towards-gender-equality 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/prevalence-of-egfr-and-alk-mutations-in-lung-adenocarcinomas-in-the-levant-area-a-prospective-analysis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/a-nationwide-non-interventional-epidemiological-data-registry-on-myelodysplastic-syndromes-in-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/expression-of-eukaryotic-initiation-factor-4e-and-4e-binding-protein-1-in-colorectal-carcinogenesis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/effective-targeting-of-chronic-myeloid-leukemia-initiating-activity-with-the-combination-of-arsenic-trioxide-and-interferon-alpha 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/a-collaborative-nationwide-lymphoma-study-in-lebanon-incidence-of-various-subtypes-and-analysis-of-associations-with-viruses 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/circulating-mir-150-and-mir-342-in-plasma-are-novel-potential-biomarkers-for-acute-myeloid-leukemia 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/a-phase-ii-study-of-lipoplatin-liposomal-cisplatin-vinorelbine-combination-in-her-2-neu-negative-metastatic-breast-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/adult-t-cell-leukemia-lymphoma-in-the-middle-east-first-report-of-two-cases-from-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/a-clinical-phase-ii-study-of-a-non-anthracycline-sequential-combination-of-cisplatin-vinorelbine-followed-by-docetaxel-as-first-line-treatment-in-metastatic-breast-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/a-clinical-phase-ii-study-of-cisplatinum-and-vinorelbine-pvn-in-advanced-breast-carcinoma-abc 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/effective-treatment-of-hypereosinophilic-syndrome-with-imatinib-mesylate 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/tamoxifen-and-endometrial-pathologies-a-prospective-study 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/myelomonocytic-antigen-abnormalities-on-neutrophils-and-monocytes-in-myelodysplastic-syndromes 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/candidemia-in-immunocompromised-patients 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/concentrations-of-ofloxacin-in-serum-and-cerebrospinal-fluid-of-patients-without-meningitis-receiving-the-drug-intravenously-and-orally 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/comparative-study-of-two-common-tests-for-lupus-anticoagulant-determination-critical-analysis-of-the-results-observed-in-21-patients 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/eosinophilic-fasciitis-and-severe-aplastic-anemia-favorable-response-to-either-antithymocyte-globulin-or-cyclosporine-a-in-blood-and-skin-disorders 2026-08-10T10:47:39+01:00 https://nizarbitar.com/media/cytosine-arabinoside-for-induction-salvage-and-consolidation-therapy-of-adult-acute-lymphoblastic-leukemia 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/professor-nizar-bitar-representing-lsmo-at-the-launch-of-said-ngo-s-march-2023-campaign 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/professor-nizar-bitar-explains-colon-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/professor-nizar-bitar-at-the-said-ngo-hike-to-yahshoush-part-2 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/sahtak-your-health-professor-nizar-bitar-on-nbn-blood-diseases-cancer-care 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/sahtak-your-health-professor-nizar-bitar-on-nbn-hematology-oncology 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/sahtak-your-health-professor-nizar-bitar-on-nbn-head-of-hematology-oncology-at-sahel-general-hospital 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/shi-jdid-something-new-professor-nizar-bitar-on-blood-diseases-and-cancer-nbn 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/cancer-patients-in-lebanon-and-their-many-battles-panel-with-professor-nizar-bitar-lbci-naharkoun-saeed 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/professor-nizar-bitar-s-address-representing-the-dean-of-the-faculty-of-medical-sciences 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/early-breast-cancer-detection-campaign-awareness-lecture-by-professor-nizar-bitar-women-s-advancement-association 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/morning-news-interview-with-professor-nizar-bitar-future-tv 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/early-breast-cancer-detection-awareness-lecture-with-professor-nizar-bitar-october-campaign 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/breast-cancer-awareness-tips-from-professor-nizar-bitar 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/evaluating-cancer-risks-the-impact-of-thirdhand-smoke-exposure-on-carcinogenesis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/complex-presentation-of-multicentric-castleman-disease-with-coexisting-hiv-hhv-8-and-other-opportunistic-infections 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/liquid-biopsy-as-a-tool-for-kras-nras-braf-baseline-testing-in-metastatic-colorectal-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/consensus-on-the-management-of-platinum-sensitive-high-grade-serous-epithelial-ovarian-cancer-in-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/diagnosis-and-management-of-patients-with-stage-iii-non-small-cell-lung-cancer-a-joint-statement-by-the-lebanese-society-of-medical-oncology-and-the-lebanese-pulmonary-society 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/lung-cancer-screening-in-lebanon-joint-statement-from-the-lebanese-pulmonary-society-and-the-lebanese-society-of-medical-oncology 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/pneumococcal-disease-in-high-risk-adults-in-lebanon-expert-opinion 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/incidence-of-braf-v600e-gene-mutation-among-lebanese-population-in-melanoma-and-colorectal-cancer-a-retrospective-study-between-2010-and-2019 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/the-first-middle-east-and-north-africa-expert-consensus-recommendations-for-the-management-of-advanced-colorectal-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/overcoming-therapy-resistance-in-colon-cancer-by-drug-repurposing 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/large-cell-neuroendocrine-carcinoma-of-the-colon-with-brain-metastasis-a-case-report 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/dermatomyositis-a-presenting-clinical-vignette-in-a-patient-with-breast-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/a-case-report-first-report-of-a-primary-breast-leiomyosarcoma-with-lymph-node-metastasis-in-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/the-lebanese-society-of-medical-oncology-lsmo-recommendations-and-perspectives-on-oncology-care-during-the-covid-19-pandemic 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/the-lebanese-society-of-medical-oncology-lsmo-statement-on-the-care-of-patients-with-cancer-during-the-covid-19-pandemic 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/management-of-patients-with-high-risk-and-advanced-prostate-cancer-in-the-middle-east-resource-stratified-consensus-recommendations 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/circulating-mir-29c-mir-30c-mir-193a-5p-and-mir-885-5p-novel-potential-biomarkers-for-htlv-1-infection-diagnosis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/female-oncologists-in-the-middle-east-and-north-africa-progress-towards-gender-equality 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/prevalence-of-egfr-and-alk-mutations-in-lung-adenocarcinomas-in-the-levant-area-a-prospective-analysis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/a-nationwide-non-interventional-epidemiological-data-registry-on-myelodysplastic-syndromes-in-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/expression-of-eukaryotic-initiation-factor-4e-and-4e-binding-protein-1-in-colorectal-carcinogenesis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/effective-targeting-of-chronic-myeloid-leukemia-initiating-activity-with-the-combination-of-arsenic-trioxide-and-interferon-alpha 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/a-collaborative-nationwide-lymphoma-study-in-lebanon-incidence-of-various-subtypes-and-analysis-of-associations-with-viruses 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/circulating-mir-150-and-mir-342-in-plasma-are-novel-potential-biomarkers-for-acute-myeloid-leukemia 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/a-phase-ii-study-of-lipoplatin-liposomal-cisplatin-vinorelbine-combination-in-her-2-neu-negative-metastatic-breast-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/adult-t-cell-leukemia-lymphoma-in-the-middle-east-first-report-of-two-cases-from-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/a-clinical-phase-ii-study-of-a-non-anthracycline-sequential-combination-of-cisplatin-vinorelbine-followed-by-docetaxel-as-first-line-treatment-in-metastatic-breast-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/a-clinical-phase-ii-study-of-cisplatinum-and-vinorelbine-pvn-in-advanced-breast-carcinoma-abc 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/effective-treatment-of-hypereosinophilic-syndrome-with-imatinib-mesylate 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/tamoxifen-and-endometrial-pathologies-a-prospective-study 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/myelomonocytic-antigen-abnormalities-on-neutrophils-and-monocytes-in-myelodysplastic-syndromes 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/candidemia-in-immunocompromised-patients 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/concentrations-of-ofloxacin-in-serum-and-cerebrospinal-fluid-of-patients-without-meningitis-receiving-the-drug-intravenously-and-orally 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/comparative-study-of-two-common-tests-for-lupus-anticoagulant-determination-critical-analysis-of-the-results-observed-in-21-patients 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/eosinophilic-fasciitis-and-severe-aplastic-anemia-favorable-response-to-either-antithymocyte-globulin-or-cyclosporine-a-in-blood-and-skin-disorders 2026-08-10T10:47:39+01:00 https://nizarbitar.com/fr/media/cytosine-arabinoside-for-induction-salvage-and-consolidation-therapy-of-adult-acute-lymphoblastic-leukemia 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/professor-nizar-bitar-representing-lsmo-at-the-launch-of-said-ngo-s-march-2023-campaign 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/professor-nizar-bitar-explains-colon-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/professor-nizar-bitar-at-the-said-ngo-hike-to-yahshoush-part-2 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/sahtak-your-health-professor-nizar-bitar-on-nbn-blood-diseases-cancer-care 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/sahtak-your-health-professor-nizar-bitar-on-nbn-hematology-oncology 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/sahtak-your-health-professor-nizar-bitar-on-nbn-head-of-hematology-oncology-at-sahel-general-hospital 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/shi-jdid-something-new-professor-nizar-bitar-on-blood-diseases-and-cancer-nbn 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/cancer-patients-in-lebanon-and-their-many-battles-panel-with-professor-nizar-bitar-lbci-naharkoun-saeed 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/professor-nizar-bitar-s-address-representing-the-dean-of-the-faculty-of-medical-sciences 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/early-breast-cancer-detection-campaign-awareness-lecture-by-professor-nizar-bitar-women-s-advancement-association 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/morning-news-interview-with-professor-nizar-bitar-future-tv 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/early-breast-cancer-detection-awareness-lecture-with-professor-nizar-bitar-october-campaign 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/breast-cancer-awareness-tips-from-professor-nizar-bitar 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/evaluating-cancer-risks-the-impact-of-thirdhand-smoke-exposure-on-carcinogenesis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/complex-presentation-of-multicentric-castleman-disease-with-coexisting-hiv-hhv-8-and-other-opportunistic-infections 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/liquid-biopsy-as-a-tool-for-kras-nras-braf-baseline-testing-in-metastatic-colorectal-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/consensus-on-the-management-of-platinum-sensitive-high-grade-serous-epithelial-ovarian-cancer-in-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/diagnosis-and-management-of-patients-with-stage-iii-non-small-cell-lung-cancer-a-joint-statement-by-the-lebanese-society-of-medical-oncology-and-the-lebanese-pulmonary-society 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/lung-cancer-screening-in-lebanon-joint-statement-from-the-lebanese-pulmonary-society-and-the-lebanese-society-of-medical-oncology 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/pneumococcal-disease-in-high-risk-adults-in-lebanon-expert-opinion 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/incidence-of-braf-v600e-gene-mutation-among-lebanese-population-in-melanoma-and-colorectal-cancer-a-retrospective-study-between-2010-and-2019 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/the-first-middle-east-and-north-africa-expert-consensus-recommendations-for-the-management-of-advanced-colorectal-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/overcoming-therapy-resistance-in-colon-cancer-by-drug-repurposing 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/large-cell-neuroendocrine-carcinoma-of-the-colon-with-brain-metastasis-a-case-report 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/dermatomyositis-a-presenting-clinical-vignette-in-a-patient-with-breast-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/a-case-report-first-report-of-a-primary-breast-leiomyosarcoma-with-lymph-node-metastasis-in-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/the-lebanese-society-of-medical-oncology-lsmo-recommendations-and-perspectives-on-oncology-care-during-the-covid-19-pandemic 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/the-lebanese-society-of-medical-oncology-lsmo-statement-on-the-care-of-patients-with-cancer-during-the-covid-19-pandemic 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/management-of-patients-with-high-risk-and-advanced-prostate-cancer-in-the-middle-east-resource-stratified-consensus-recommendations 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/circulating-mir-29c-mir-30c-mir-193a-5p-and-mir-885-5p-novel-potential-biomarkers-for-htlv-1-infection-diagnosis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/female-oncologists-in-the-middle-east-and-north-africa-progress-towards-gender-equality 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/prevalence-of-egfr-and-alk-mutations-in-lung-adenocarcinomas-in-the-levant-area-a-prospective-analysis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/a-nationwide-non-interventional-epidemiological-data-registry-on-myelodysplastic-syndromes-in-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/expression-of-eukaryotic-initiation-factor-4e-and-4e-binding-protein-1-in-colorectal-carcinogenesis 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/effective-targeting-of-chronic-myeloid-leukemia-initiating-activity-with-the-combination-of-arsenic-trioxide-and-interferon-alpha 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/a-collaborative-nationwide-lymphoma-study-in-lebanon-incidence-of-various-subtypes-and-analysis-of-associations-with-viruses 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/circulating-mir-150-and-mir-342-in-plasma-are-novel-potential-biomarkers-for-acute-myeloid-leukemia 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/a-phase-ii-study-of-lipoplatin-liposomal-cisplatin-vinorelbine-combination-in-her-2-neu-negative-metastatic-breast-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/adult-t-cell-leukemia-lymphoma-in-the-middle-east-first-report-of-two-cases-from-lebanon 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/a-clinical-phase-ii-study-of-a-non-anthracycline-sequential-combination-of-cisplatin-vinorelbine-followed-by-docetaxel-as-first-line-treatment-in-metastatic-breast-cancer 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/a-clinical-phase-ii-study-of-cisplatinum-and-vinorelbine-pvn-in-advanced-breast-carcinoma-abc 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/effective-treatment-of-hypereosinophilic-syndrome-with-imatinib-mesylate 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/tamoxifen-and-endometrial-pathologies-a-prospective-study 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/myelomonocytic-antigen-abnormalities-on-neutrophils-and-monocytes-in-myelodysplastic-syndromes 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/candidemia-in-immunocompromised-patients 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/concentrations-of-ofloxacin-in-serum-and-cerebrospinal-fluid-of-patients-without-meningitis-receiving-the-drug-intravenously-and-orally 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/comparative-study-of-two-common-tests-for-lupus-anticoagulant-determination-critical-analysis-of-the-results-observed-in-21-patients 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/eosinophilic-fasciitis-and-severe-aplastic-anemia-favorable-response-to-either-antithymocyte-globulin-or-cyclosporine-a-in-blood-and-skin-disorders 2026-08-10T10:47:39+01:00 https://nizarbitar.com/ar/media/cytosine-arabinoside-for-induction-salvage-and-consolidation-therapy-of-adult-acute-lymphoblastic-leukemia 2026-08-10T10:47:39+01:00